Targeting the NLRP3 inflammasome in inflammatory diseases

Matthew Mangan(German Center for Neurodegenerative Diseases), Edward J. Olhava(Ifm Therapeutics (United States)), William Roush(Ifm Therapeutics (United States)), H. Martin Seidel(Ifm Therapeutics (United States)), Gary D. Glick(Ifm Therapeutics (United States)), Eicke Latz(University of Massachusetts Chan Medical School)
Nature Reviews Drug Discovery
July 20, 2018
Cited by 1,875

Abstract


Related Papers

No related papers found

Powered by citation graph analysis